Clearmind Medicine Inc
CMND
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.65M
Close$
$1.22
58% downside
Current Fair Value
58% downsideOvervalued by 58% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.65 Million |
|---|---|
| Enterprise Value | $-8,975,326.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.03 |
| Beta | -1.12 |
| Outstanding Shares | 1,162,097 |
Return
| Return on Equity | -74.02% |
|---|---|
| Return on Assets | -54.72% |
| Return on Invested Capital | -76.13% |
Valuation & Multiples
| P/E Ratio | -0.54 |
|---|---|
| PEG | -0.14 |
| Price to Sales | - |
| Price to Book Ratio | 0.32 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 1.05 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.87%▲ 3.30% |
|---|---|
| Total Invested | $46,214▲ 284.70% |
| Investors Holding | 4▲ 2.00% |
ESG Score
No data